Recently, the human gene encoding erythroid-specific -aminolevulinate synthase was localized to the chromosomal region Xp2l-Xq2l, identifying this gene as the logical candidate for the enzymatic defect causing "X -linked" sideroblastic anemia. To investigate this hypothesis, the 11 exonic coding regions of the -aminolevulinate synthase gene were amplified and sequenced from a 30-year-old Chinese male with a pyridoxine-responsive form of X-linked sideroblastic anemia. A single T --A transition was found in codon 471 in a highly conserved region of exon 9, resulting in an ile -+ Asn substitution. This mutation interrupted contiguous hydrophobic residues and was predicted to transform a region of (3-sheet structure to a random-coil structure. Prokaryotic expression of the normal and mutant cDNAs revealed that the mutant construct expressed low levels of enzymatic activity that required higher concentrations of pyridoxal 5'-phosphate to achieve maximal activation than did the normal enzyme. The amino acid substitution occurred in the exon containing the putative pyridoxal 5'-phosphate binding site and may account for the reduced ability of the cofactor to catalyze the formation of 6aminolevulinic acid.The sideroblastic anemias are a clinically heterogeneous group of disorders resulting from inherited or acquired causes (1, 2). The inherited types are X chromosome-linked or autosomal, and the acquired forms are secondary to chemical induction or to inflammatory disease or are idiopathic. Patients in these classifications can be further subdivided into those who are responsive to pyridoxine and those who are refractory. Sideroblastic anemia is classified as a disorder of heme synthesis since the activities of certain heme biosynthetic enzymes were reported to be deficient (3), whereas globin synthesis was normal. Since many patients had reduced 8-aminolevulinate synthase [ALAS; succinylCoA:glycine C-succinyltransferase (decarboxylating); EC 2.3.1.37] enzymatic activity in bone marrow (4, 5) and because pyridoxal 5'-phosphate (PLP), the pyridoxine metabolite, is a required cofactor, ALAS has been suggested as a candidate gene for mutations leading to some types of sideroblastic anemia (6).The human genes encoding the housekeeping and erythroid forms of ALAS were isolated and characterized (7-9). Although the two genes predicted proteins with 59% amino acid identity, they were mapped to different chromosomes by somatic cell hybrid and in situ hybridization methods. The housekeeping gene mapped to chromosome 3p2l, and the erythroid gene was localized to the X chromosomal region Xp2l-Xq2l (9-13). The X-chromosomal assignment suggested that the erythroid form of ALAS (designated ALAS2) might be the enzymatic defect in "X-linked" sideroblastic anemia (XLSA).To investigate this hypothesis, the erythroid ALAS2 coding regions were amplified and sequenced from a male affected with pyridoxine-responsive XLSA. In this communication, an exonic point mutation in the ALAS2 gene that predicted the substitution of asparagine f...